Briacell Therapeutics Corp

NASDAQ BCTX

Download Data

Briacell Therapeutics Corp Market Capitalization on June 03, 2024: USD 27.98 M

Briacell Therapeutics Corp Market Capitalization is USD 27.98 M on June 03, 2024, a -72.45% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.
  • Briacell Therapeutics Corp 52-week high Market Capitalization is USD 124.19 M on August 25, 2023, which is 343.93% above the current Market Capitalization.
  • Briacell Therapeutics Corp 52-week low Market Capitalization is USD 25.05 M on May 28, 2024, which is -10.46% below the current Market Capitalization.
  • Briacell Therapeutics Corp average Market Capitalization for the last 52 weeks is USD 74.88 M.
NASDAQ: BCTX

Briacell Therapeutics Corp

CEO Dr. William V. Williams M.D.
IPO Date Feb. 24, 2021
Location Canada
Headquarters Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1
Employees 16
Sector Healthcare
Industry Biotechnology
Description

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Similar companies

DAWN

Day One Biopharmaceuticals Inc

USD 13.18

-0.68%

HEPA

Hepion Pharmaceuticals Inc

USD 1.16

-7.94%

StockViz Staff

September 8, 2024

Any question? Send us an email